Pharmaceutical composition of chondroitin sulfate and celocexib. The present invention relates to a pharmaceutical composition of chondroitin sulfate and celecoxib. In particular, it relates to a composition for oral administration in which the weight ratio between chondroitin sulfate and celecoxib is between 1.5: 1 and 2.5: 1, a ratio which is particularly effective for the treatment of damaged cartilages. In patients with osteoarthritis. It also refers to a pharmaceutical unit dosage form, in particular a tablet and a capsule, comprising a therapeutically effective amount of said composition. It also relates to the use of said composition for the preparation of a medicament for the treatment of osteoarthritis. (Machine-translation by Google Translate, not legally binding)
展开▼
